We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
-12.98%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$78.3M
Cap. Flow
-$27.2M
Cap. Flow %
-11.28%
Top 10 Hldgs %
56%
Holding
50
New
12
Increased
8
Reduced
19
Closed
9

Top Buys

Rank Stock Value
1
VPG icon
Vishay Precision Group
VPG
+$6.15M
2
DOMO icon
Domo
DOMO
+$6.02M
3
AKBA icon
Akebia Therapeutics
AKBA
+$5.97M
4
HRTX icon
Heron Therapeutics
HRTX
+$5.39M
5
ZVRA icon
Zevra Therapeutics
ZVRA
+$5.16M

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$16.6M
2
DCTH icon
Delcath Systems
DCTH
+$16M
3
TARS icon
Tarsus Pharmaceuticals
TARS
+$12.4M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$8.73M
5
GLW icon
Corning
GLW
+$3.7M

Sector Composition

Rank Sector Weight
1 Healthcare 50.86%
2 Technology 21.98%
3 Industrials 6.95%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$439B
$32.8M 13.59%
+70,000
New +$35.6M
VSTM icon
2
Verastem
VSTM
$523M
$14.1M 5.84%
2,337,754
-327,289
-12% -$2M
MYO icon
3
Myomo
MYO
$36.7M
$14M 5.79%
2,906,689
-474,878
-14% -$2.71M
PSNL icon
4
Personalis
PSNL
$1.24B
$13.9M 5.77%
3,968,948
+169,884
+4% +$807K
ARQ icon
5
Arq
ARQ
$81.6M
$11.6M 4.78%
2,770,278
-46,800
-2% -$266K
SCPH
6
DELISTED
scPharmaceuticals
SCPH
$10.8M 4.46%
4,096,367
-78,000
-2% -$254K
ZVRA icon
7
Zevra Therapeutics
ZVRA
$568M
$10.8M 4.46%
1,438,109
+649,495
+82% +$5.16M
BKTI icon
8
BK Technologies
BKTI
$293M
$10.5M 4.35%
268,180
– –
ELUT icon
9
Elutia
ELUT
$39.8M
$8.55M 3.54%
3,381,415
+306,740
+10% +$927K
BLZE icon
10
Backblaze
BLZE
$696M
$8.27M 3.42%
1,712,321
-87,679
-5% -$540K
GLW icon
11
CALL
Corning
GLW
$107B
$8.01M 3.32%
175,000
-500,000
-74% -$24.7M
IWM icon
12
PUT
iShares Russell 2000 ETF
IWM
$79.3B
$7.98M 3.3%
+40,000
New +$8.68M
COYA icon
13
Coya Therapeutics
COYA
$92.9M
$7.66M 3.17%
1,183,780
-17,372
-1% -$110K
LPTH icon
14
Lightpath Technologies
LPTH
$592M
$7.4M 3.06%
3,682,932
-41,000
-1% -$113K
VPG icon
15
Vishay Precision Group
VPG
$1.07B
$6.35M 2.63%
+263,565
New +$6.15M
HRTX icon
16
Heron Therapeutics
HRTX
$93.1M
$6.11M 2.53%
+2,778,200
New +$5.39M
DOMO icon
17
Domo
DOMO
$174M
$5.83M 2.41%
+751,583
New +$6.02M
AKBA icon
18
Akebia Therapeutics
AKBA
$333M
$5.62M 2.32%
+2,925,000
New +$5.97M
ELVA
19
Electrovaya
ELVA
$376M
$5.24M 2.17%
2,262,323
-262,776
-10% -$649K
IDN icon
20
Intellicheck
IDN
$74.7M
$4.84M 2%
1,597,538
-20,158
-1% -$53.1K
ANGO icon
21
AngioDynamics
ANGO
$597M
$4.46M 1.84%
+474,488
New +$4.99M
IPWR icon
22
Ideal Power
IPWR
$56.3M
$4.26M 1.76%
818,315
-5,000
-0.6% -$31.4K
RNXT icon
23
RenovoRx
RNXT
$40.2M
$3.43M 1.42%
+3,467,275
New +$4.04M
DCTH icon
24
Delcath Systems
DCTH
$400M
$3.32M 1.37%
260,719
-1,124,670
-81% -$16M
THTX
25
DELISTED
Theratechnologies
THTX
$3.26M 1.35%
2,326,569
-700,000
-23% -$1.17M
1
2

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, AIGH Capital Management held 50 positions worth $242M, down 24% from $320M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

AIGH Capital Management withdrew a net $27.2M in Q1 2025, closing 9 positions and reducing 19 holdings. Its most notable exit was Marvell Technology, an estimated $16.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Vishay Precision Group worth $6.35M.

  • AIGH Capital Management's largest Q1 2025 buy was Vishay Precision Group: 263,565 shares worth $6.35M.
  • AIGH Capital Management added most to Zevra Therapeutics in Q1 2025, an estimated $5.16M increase.
  • AIGH Capital Management's biggest Q1 2025 reduction was Delcath Systems, cutting an estimated $16M.
  • AIGH Capital Management fully exited Marvell Technology in Q1 2025, selling an estimated $16.6M.
  • AIGH Capital Management's ten largest holdings make up 56% of its $242M portfolio in Q1 2025.
  • AIGH Capital Management opened 12 new positions and closed 9 in Q1 2025.
  • AIGH Capital Management's portfolio value fell 24% quarter-over-quarter to $242M.

Based on AIGH Capital Management's 13F filing for Q1 2025, filed 6 May 2025.